Sarah Winawer-Wetzel, MBA, FACHE
banner
sarahwinwetz.bsky.social
Sarah Winawer-Wetzel, MBA, FACHE
@sarahwinwetz.bsky.social
📌 Now: Strategy & Ops at @pc3innovation.bsky.social

🏢 Past: @danafarber.bsky.social, Penn Medicine Palliative Care

🎓 BA @smith-college.bsky.social
🎓 MBA @brandeisuniversity.bsky.social

🌈 she/her | all posts are my own
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
💉Reminder! Don't forget to get your yearly Flu and COVID vaccine. Cases of both will start increasing soon 📈

Check with your medical providers, local pharmacies, and/or local health departments for COVID vaccine availability.

#wildtomild
October 14, 2025 at 1:12 PM
Samira Daswani's presentation is about how healthcare is designed. It is also one of the best designed presentations I've seen in years. The clarity and efficiency of the deck is literally reinforcing her point about the need for improved design in healthcare. #ASCOQLTY25
October 10, 2025 at 1:27 PM
Just got my registration in before the early bird deadline closed for #ASCOQLTY25. Who else is going?
September 3, 2025 at 5:58 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
We are thrilled to welcome 6 new Faculty, 3 Fellows, and 2 Visiting Faculty to PC3I! Stay tuned over the next few weeks as we introduce each new member!
PC3I Welcomes New Faculty and Fellows - Penn Center for Cancer Care Innovation
The Penn Center for Cancer Care Innovation proudly welcomes 6 faculty, 3 fellows, and 2 visiting faculty to the team.
pc3i.upenn.edu
July 31, 2025 at 4:03 PM
"Where do those patients go when the last stop was your safety net hospitals? We don’t have another system to be able to take care of them."
July 29, 2025 at 2:07 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
Patients with prior authorization requirements are more likely to have their access to #chemotherapy interrupted- facing a 10-day delay on average.

PC3I Faculty @michaelannica.bsky.social spoke with @nytimes.com on the effects of health insurers denying drug claims for patients.
Health Insurers Are Denying More Drug Claims, Data Shows
www.nytimes.com
July 22, 2025 at 1:00 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
Trans youth deserve the health care they need, no matter what state they live in.
June 24, 2025 at 8:29 PM
Medicaid access isn't just important, it's essential for patients' cancer care. Contact your lawmakers today and urge them to protect Medicaid, ensuring uninterrupted care for those who need it most. @ascocancer.bsky.social #ACTNetwork

asco.quorum.us/campaign/115...
Medicaid
Urge Congress to Protect Cancer Patients on Medicaid
asco.quorum.us
June 11, 2025 at 4:48 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
My message to Trump’s NIH Director? No one in America wants us to do LESS cancer research.

No one is asking Trump to make it harder to cure Alzheimer's disease.

Yet Trump is cutting all of this NOW and demanding an $18 BILLION cut to NIH next year. Not on my watch.
June 10, 2025 at 6:53 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
PC3I Faculty, Fellows, & staff will present 32 abstracts this weekend at the 2025 @ascocancer.bsky.social Annual Meeting.

PC3I's work focuses on delivering patient-centered care, addressing socioeconomic barriers in #oncology, & applying digital interventions to improve patient care. #ASCO25
PC3I Presents 32 Abstracts at the 2025 ASCO Annual Meeting - Penn Center for Cancer Care Innovation
PC3I Faculty, Fellows, and staff present 32 Abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
pc3i.upenn.edu
May 30, 2025 at 2:35 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
Since being sworn in to lead HHS, Kennedy has overseen significant layoffs across its agencies and canceled billions of dollars in federal grants to universities and state public health departments.
https://cancerletter.com/capitol-hill/20250516_2/
Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges...
In back-to-back congressional hearings earlier this week, HHS Secretary Robert F. Kennedy Jr. said that the massive staff and budget cuts over which he has presided during his nearly four months on the job as well as even bigger cuts still looming on the horizon are a part of a single plan. To access this […]
cancerletter.com
May 22, 2025 at 6:00 PM
This is devastating and deeply frustrating news:
-No updates to cancer.gov website or NCI social media.
-No updates to the Physician Data Query database.
-No one to answer the patient hotline.

We can no longer rely on the federal government to provide information that supports public health.
May 13, 2025 at 1:31 PM
New editorial in @implementsci.bsky.social by @rsbeidas.bsky.social et al on NIH's #impsci grant terminations. This was important, peer-reviewed research on health equity, HIV, infectious diseases, etc. There will be long-lasting impacts.

implementationscience.biomedcentral.com/articles/10....
Implementation science grant terminations in the United States - Implementation Science
implementationscience.biomedcentral.com
May 8, 2025 at 7:03 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
Reminder to nominate yourself or someone else by April 18 to join PC3I's team of innovators in #cancercare!

Learn more: pc3i.upenn.edu/get-involved...
April 16, 2025 at 1:12 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
'Bluesky has overtaken its flailing rival X in hosting posts related to new academic research, indicating the platform is fast becoming the go-to place for scholars to share their work.'
X’s dominance ‘over’ as Bluesky becomes new hub for research
Data indicates more scholars turning to alternative social media site to post about their work after Elon Musk’s Twitter takeover
www.timeshighereducation.com
April 9, 2025 at 7:14 AM
Want to be part of a fantastic community working to solve the most intractable problems in cancer care today? @pc3innovation.bsky.social is currently accepting nominees for faculty and fellows!

CC: @upenn.bsky.social, @pennmedicine.bsky.social, @penncancer.bsky.social
PC3I is seeking change agents in #cancer care and delivery to join us as Faculty and Fellows for FY26!

Learn more about the roles here: pc3i.upenn.edu/get-involved...

Fill out this form to nominate yourself or someone else by April 18: redcap.med.upenn.edu/surveys/?s=C...
April 10, 2025 at 1:19 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
THREAD

The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter

In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.

By quite a lot.

Release the Kraken...

#AcademicSky #HigherEd #Altmetrics
1/11
March 27, 2025 at 5:22 PM
"A hefty percentage of raw ingredients used to make major drugs come from China, and tariffs are expected to affect cancer and heart medicines as well as antibiotics, including amoxicillin."
March 25, 2025 at 1:57 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
"Protecting these institutions is vital—not just for scientific advancement but for the millions of patients who rely on them for hope and cutting-edge care," write Shannon McWeeney (@wondermixtape.bsky.social) and Sorena Nadaf-Rahrov
https://cancerletter.com/guest-editorial/20250321_2/
Caught in the crossfire: The critical threats facing cancer centers, research, and patient care - The Cancer Letter
NCI-designated cancer centers and academic medical institutions (AMCs) are facing unprecedented threats that jeopardize their ability to conduct groundbreaking research, deliver cutting-edge care, and sustain clinical trials essential to patient treatment. Funding instability, including freezes on federal grants and sudden cuts to indirect cost rates, is creating a ripple effect that disrupts the entire cancer […]
cancerletter.com
March 25, 2025 at 12:00 PM
Anna Jo Smith, MD, MPH (@pc3innovation.bsky.social faculty) found that a blood test is more likely to miss #ovariancancer in Black & Native American patients—revealing critical disparities in early detection & the need for more equitable #cancercare. @jama.com

jamanetwork.com/journals/jam...
CA-125 Levels at Time of Ovarian Cancer Diagnosis by Race and Ethnicity
This cohort study uses National Cancer Database data to examine cancer antigen (CA) 125 levels at ovarian cancer diagnosis by patient race and ethnicity and whether elevated CA-125 levels are associat...
jamanetwork.com
March 25, 2025 at 1:21 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
Via Abigail André on LinkedIn - please spread the word.
Here are updated forms for Federal Cuts Tracker Map project, live later this week.

If you're new to the project, it is an interactive map that is tracking the impacts of federal cuts around the globe. 1/x
www.linkedin.com/posts/abigai...
Abigail André on LinkedIn: #data #federalgovernment #federalworkers #usaid #noaa #federalcuts #stories | 131 comments
Here are updated forms for Federal Cuts Tracker Map project, live later this week. If you're new to the project, it is an interactive map that is tracking… | 131 comments on LinkedIn
www.linkedin.com
March 3, 2025 at 3:27 PM
Reposted by Sarah Winawer-Wetzel, MBA, FACHE
From Abigail Andre over on LinkedIn:

Federal Cuts Tracker Map will be live next week.

It is an interactive visualization of impacts felt across the country as the result of federal firings, funding freezes and cuts, and program cancellations.

🧪
Tracking Federal Cuts Mapping Project
This form allows you to contribute to the Tracking Federal Cuts Map with local stories about how the cuts are impacting your community. The goal of this is to better inform the public about the impa...
lnkd.in
February 28, 2025 at 7:07 PM
If you followed us on #thatothersite, give us a follow here!
PC3I is now on BlueSky!
The Penn Center for Cancer Care Innovation creates, tests, & scales solutions to improve cancer care delivery, efficiency, & value. Our work spans the entire cancer continuum, from prevention to treatment, survivorship, & end-of-life care. Learn more: pc3i.upenn.edu/our-work/
Our Work - Penn Center for Cancer Care Innovation
We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
pc3i.upenn.edu
March 19, 2025 at 9:28 PM